Author/Authors :
Ebrahimi, Saeedeh Department of Medical Microbiology (Bacteriology & Virology) - Afzalipour Faculty of Medicine - Kerman University of Medical Sciences, Kerman, Iran , Khanbabaei, Hashem Department of Radiologic Technology - Faculty of Allied Medicine - Kerman University of Medical Sciences, Kerman, Iran , Abbasi, Samaneh Abadan University of Medical Sciences, Abadan, Iran , Fani, Mona Department of Pathobiology and Laboratory Sciences - School of Medicine - North Khorasan University of Medical Sciences, Bojnurd, Iran , Soltani, Saber Department of Virology - School of Public Health - Tehran University of Medical Sciences, Tehran, Iran , Zandi, Milad Department of Virology - School of Public Health - Tehran University of Medical Sciences, Tehran, Iran , Najafimemar, Zahra Infectious Diseases Research Center - Golestan University of Medical Sciences, Gorgan, Iran
Abstract :
More than a year has passed since the beginning of the 2019 novel coronavirus diseas-es (COVID-19) pandemic which has created massive problems globally affecting all aspects of people's life. Due to the emergence of new strains of the SARS-CoV-2, pan-demic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19.
